{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:16:35Z","timestamp":1787588195694,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-025-02005-z","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T07:40:08Z","timestamp":1748072408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Viral-mediated knockdown of Atxn2 attenuates TDP-43 pathology and muscle dysfunction in the PFN1C71G ALS mouse model"],"prefix":"10.1186","volume":"13","author":[{"given":"Zachary C. E.","family":"Hawley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"Bodnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzheng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Sheehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria I.","family":"Zavodszky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaolong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Isaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Jandreski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Carlile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ching","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Grimard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Bourque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Utturkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Desmarais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Moore","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dann","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Guilmette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah Y.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"2005_CR1","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.mayocp.2018.04.007","volume":"93","author":"B Oskarsson","year":"2018","unstructured":"Oskarsson B, Gendron TF, Staff NP (2018) Amyotrophic lateral sclerosis: an update for 2018. Mayo Clin Proc 93:1617\u20131628","journal-title":"Mayo Clin Proc"},{"key":"2005_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-008-0477-9","volume":"117","author":"M Neumann","year":"2009","unstructured":"Neumann M et al (2009) Phosphorylation of S409\/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol 117:137\u2013149","journal-title":"Acta Neuropathol"},{"key":"2005_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41593-018-0300-4","volume":"22","author":"JR Klim","year":"2019","unstructured":"Klim JR et al (2019) ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat Neurosci 22:167\u2013179","journal-title":"Nat Neurosci"},{"key":"2005_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1523\/JNEUROSCI.4988-09.2010","volume":"30","author":"SJ Barmada","year":"2010","unstructured":"Barmada SJ et al (2010) Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci 30:639\u2013649","journal-title":"J Neurosci"},{"key":"2005_CR5","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/hmg\/ddp534","volume":"19","author":"E Kabashi","year":"2010","unstructured":"Kabashi E et al (2010) Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum Mol Genet 19:671\u2013683","journal-title":"Hum Mol Genet"},{"key":"2005_CR6","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1126\/science.abq5622","volume":"379","author":"MW Baughn","year":"2023","unstructured":"Baughn MW et al (2023) Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies. Science 379:1140\u20131149","journal-title":"Science"},{"key":"2005_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-022-04436-3","volume":"603","author":"AL Brown","year":"2022","unstructured":"Brown AL et al (2022) TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature 603:131\u2013137","journal-title":"Nature"},{"key":"2005_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41586-022-04424-7","volume":"603","author":"XR Ma","year":"2022","unstructured":"Ma XR et al (2022) TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. Nature 603:124\u2013130","journal-title":"Nature"},{"key":"2005_CR9","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1073\/pnas.0912417107","volume":"107","author":"H Wils","year":"2010","unstructured":"Wils H et al (2010) TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA 107:3858\u20133863","journal-title":"Proc Natl Acad Sci USA"},{"key":"2005_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nature22038","volume":"544","author":"LA Becker","year":"2017","unstructured":"Becker LA et al (2017) Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature 544:367\u2013371","journal-title":"Nature"},{"key":"2005_CR11","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature09320","volume":"466","author":"AC Elden","year":"2010","unstructured":"Elden AC et al (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466:1069\u20131075","journal-title":"Nature"},{"key":"2005_CR12","doi-asserted-by":"publisher","first-page":"178.e1","DOI":"10.1016\/j.neurobiolaging.2016.11.010","volume":"51","author":"W Sproviero","year":"2017","unstructured":"Sproviero W et al (2017) ATXN2 trinucleotide repeat length correlates with risk of ALS. Neurobiol Aging 51:178.e1-178.e9","journal-title":"Neurobiol Aging"},{"key":"2005_CR13","doi-asserted-by":"publisher","first-page":"6492","DOI":"10.1038\/s41467-023-42147-z","volume":"14","author":"CM Zeballos","year":"2023","unstructured":"Zeballos CM et al (2023) Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins. Nat Commun 14:6492","journal-title":"Nat Commun"},{"key":"2005_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13024-024-00732-w","volume":"19","author":"RP Carmen-Orozco","year":"2024","unstructured":"Carmen-Orozco RP et al (2024) Elevated nuclear TDP-43 induces constitutive exon skipping. Mol Neurodegener 19:45","journal-title":"Mol Neurodegener"},{"key":"2005_CR15","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1091\/mbc.e15-11-0799","volume":"27","author":"M Nejedla","year":"2016","unstructured":"Nejedla M et al (2016) Profilin connects actin assembly with microtubule dynamics. Mol Biol Cell 27:2381\u20132393","journal-title":"Mol Biol Cell"},{"key":"2005_CR16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2024605118","author":"EJ Schmidt","year":"2021","unstructured":"Schmidt EJ et al (2021) ALS-linked PFN1 variants exhibit loss and gain of functions in the context of formin-induced actin polymerization. Proc Natl Acad Sci USA. https:\/\/doi.org\/10.1073\/pnas.2024605118","journal-title":"Proc Natl Acad Sci USA"},{"key":"2005_CR17","doi-asserted-by":"publisher","first-page":"e3534","DOI":"10.1016\/j.cub.2017.10.002","volume":"27","author":"JL Henty-Ridilla","year":"2017","unstructured":"Henty-Ridilla JL, Juanes MA, Goode BL (2017) Profilin directly promotes microtubule growth through residues mutated in amyotrophic lateral sclerosis. Curr Biol 27:e3534","journal-title":"Curr Biol"},{"key":"2005_CR18","doi-asserted-by":"publisher","first-page":"23464","DOI":"10.1074\/jbc.M116.729152","volume":"291","author":"K Matsukawa","year":"2016","unstructured":"Matsukawa K et al (2016) Familial amyotrophic lateral sclerosis-linked mutations in profilin 1 exacerbate TDP-43-induced degeneration in the retina of drosophila melanogaster through an increase in the cytoplasmic localization of TDP-43. J Biol Chem 291:23464\u201323476","journal-title":"J Biol Chem"},{"key":"2005_CR19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nature11280","volume":"488","author":"CH Wu","year":"2012","unstructured":"Wu CH et al (2012) Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature 488:499\u2013503","journal-title":"Nature"},{"key":"2005_CR20","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/hmg\/ddw024","volume":"25","author":"Y Tanaka","year":"2016","unstructured":"Tanaka Y, Nonaka T, Suzuki G, Kametani F, Hasegawa M (2016) Gain-of-function profilin 1 mutations linked to familial amyotrophic lateral sclerosis cause seed-dependent intracellular TDP-43 aggregation. Hum Mol Genet 25:1420\u20131433","journal-title":"Hum Mol Genet"},{"issue":"1602","key":"2005_CR21","first-page":"e1617","volume":"36","author":"BN Smith","year":"2015","unstructured":"Smith BN et al (2015) Novel mutations support a role for profilin 1 in the pathogenesis of ALS. Neurobiol Aging 36(1602):e1617-1627","journal-title":"Neurobiol Aging"},{"key":"2005_CR22","doi-asserted-by":"publisher","first-page":"E6209","DOI":"10.1073\/pnas.1605964113","volume":"113","author":"C Yang","year":"2016","unstructured":"Yang C et al (2016) Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity. Proc Natl Acad Sci USA 113:E6209\u2013E6218","journal-title":"Proc Natl Acad Sci USA"},{"key":"2005_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/ana.26933","volume":"96","author":"M Grassano","year":"2024","unstructured":"Grassano M et al (2024) Sex differences in amyotrophic lateral sclerosis survival and progression: a multidimensional analysis. Ann Neurol 96:159\u2013169","journal-title":"Ann Neurol"},{"key":"2005_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ymthe.2024.11.029","volume":"33","author":"ZCE Hawley","year":"2025","unstructured":"Hawley ZCE et al (2025) Dorsal root ganglion toxicity after AAV intra-CSF delivery of a RNAi expression construct into non-human primates and mice. Mol Therapy 33:215\u2013234","journal-title":"Mol Therapy"},{"key":"2005_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jns.2015.04.032","volume":"353","author":"PA McCombe","year":"2015","unstructured":"McCombe PA et al (2015) Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis. J Neurol Sci 353:122\u2013129","journal-title":"J Neurol Sci"},{"key":"2005_CR26","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1038\/s41467-023-37630-6","volume":"14","author":"OJ Ziff","year":"2023","unstructured":"Ziff OJ et al (2023) Integrated transcriptome landscape of ALS identifies genome instability linked to TDP-43 pathology. Nat Commun 14:2176","journal-title":"Nat Commun"},{"key":"2005_CR27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41593-022-01205-3","volume":"26","author":"J Humphrey","year":"2023","unstructured":"Humphrey J et al (2023) Integrative transcriptomic analysis of the amyotrophic lateral sclerosis spinal cord implicates glial activation and suggests new risk genes. Nat Neurosci 26:150\u2013162","journal-title":"Nat Neurosci"},{"key":"2005_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105289","volume":"152","author":"J Canet-Pons","year":"2021","unstructured":"Canet-Pons J et al (2021) Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression. Neurobiol Dis 152:105289","journal-title":"Neurobiol Dis"},{"key":"2005_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105548","volume":"161","author":"Y Tian","year":"2021","unstructured":"Tian Y et al (2021) Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology. Neurobiol Dis 161:105548","journal-title":"Neurobiol Dis"},{"key":"2005_CR30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2210712120","volume":"120","author":"JB Nourse Jr","year":"2023","unstructured":"Nourse JB Jr et al (2023) Integrated regulation of dopaminergic and epigenetic effectors of neuroprotection in Parkinson\u2019s disease models. Proc Natl Acad Sci USA 120:e2210712120","journal-title":"Proc Natl Acad Sci USA"},{"key":"2005_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","volume":"15","author":"TR Suk","year":"2020","unstructured":"Suk TR, Rousseaux MWC (2020) The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener 15:45","journal-title":"Mol Neurodegener"},{"key":"2005_CR32","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00401-015-1460-x","volume":"130","author":"AK Walker","year":"2015","unstructured":"Walker AK et al (2015) Functional recovery in new mouse models of ALS\/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol 130:643\u2013660","journal-title":"Acta Neuropathol"},{"key":"2005_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddw429","author":"D Fil","year":"2016","unstructured":"Fil D et al (2016) Mutant profilin1 transgenic mice recapitulate cardinal features of motor neuron disease. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddw429","journal-title":"Hum Mol Genet"},{"key":"2005_CR34","doi-asserted-by":"publisher","first-page":"16821","DOI":"10.21037\/atm-20-7269","volume":"8","author":"Z Huang","year":"2020","unstructured":"Huang Z et al (2020) Inhibition of IL-6\/JAK\/STAT3 pathway rescues denervation-induced skeletal muscle atrophy. Ann Transl Med 8:16821","journal-title":"Ann Transl Med"},{"key":"2005_CR35","doi-asserted-by":"publisher","first-page":"D766","DOI":"10.1093\/nar\/gky955","volume":"47","author":"A Frankish","year":"2019","unstructured":"Frankish A et al (2019) GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res 47:D766\u2013D773","journal-title":"Nucleic Acids Res"},{"key":"2005_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/978-1-4939-3572-7_13","volume":"1415","author":"A Dobin","year":"2016","unstructured":"Dobin A, Gingeras TR (2016) Optimizing RNA-seq mapping with STAR. Methods Mol Biol 1415:245\u2013262","journal-title":"Methods Mol Biol"},{"key":"2005_CR37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN (2011) RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome. BMC Bioinformatics 12:323","journal-title":"BMC Bioinformatics"},{"key":"2005_CR38","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1093\/bioinformatics\/btab255","volume":"37","author":"B Gao","year":"2021","unstructured":"Gao B et al (2021) Quickomics: exploring omics data in an intuitive, interactive and informative manner. Bioinformatics 37:3670\u20133672","journal-title":"Bioinformatics"},{"key":"2005_CR39","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550","journal-title":"Genome Biol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02005-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02005-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02005-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T07:40:08Z","timestamp":1748072408000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-02005-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2005"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02005-z","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were formed in accordance with NIH Guide for the Care and Use of Experimental Animals and studies were approved by the Biogen Institutional Animal Care and Use Committee (IACUC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors are employees of Biogen (Cambridge, MA, USA).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}